Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionGamma secretase inhibitor with anti-notch activity
Molecular Target Gamma secretase
Mechanism of ActionNotch inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsTreat relapsed or refractory T cell acute lymphoblastic leukemia (ALL) and T cell lymphoblastic lymphoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today